Loading...
Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Dean Acheson

    TitleAssistant Clinical Professor
    SchoolUniversity of California, San Diego
    DepartmentPsychiatry
    Address9500 Gilman Drive #0851
    CA La Jolla 92093
    Phone619-543-8730
    vCardDownload vCard

      Collapse Overview 
      Collapse Overview
      Dr. Acheson received his B.A. in Psychology from Purdue University in 2003 and his Ph.D. in Clinical Psychology from the University at Albany, State University of New York in 2009. He completed predoctoral clinical internship and postdoctoral research training at the University of California-San Diego and VA San Diego Healthcare System. He joined the Psychiatry Department faculty in 2012. Dr. Acheson’s research attempts to understand the biobehavioral mechanisms involved in etiology and treatment of fear and anxiety-related disorders through the employment of cross-species translational paradigms with primarily psychophysiological outcomes (fear learning and extinction, prepulse inhibition). Dr. Acheson has a particular interest in facilitating learning-based mechanisms of psychotherapy via pharmacological intervention. Dr. Acheson currently serves as staff psychologist in the UCSD Obsessive Compulsive Treatment Program where he specializes in application of CBT/Exposure-based treatment strategies to “OC spectrum” disorders such as OCD, Body Dysmorphic Disorder, Compulsive Hoarding, and Habit Disorders.


      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Deslauriers J, Acheson D, Maihofer AX, Nievergelt CM, Baker DG, Geyer MA, Risbrough VB. COMT val158met polymorphism links to altered fear conditioning and extinction are modulated by PTSD and childhood trauma. Depress Anxiety. 2017 Aug 18. PMID: 28833952.
        View in: PubMed
      2. Glenn DE, Acheson D, Geyer MA, Nievergelt CM, Baker DG, Risbrough VB. Fear learning alterations after traumatic brain injury and their role in development of posttraumatic stress symptoms. Depress Anxiety. 2017 Aug; 34(8):723-733. PMID: 28489272.
        View in: PubMed
      3. Straus LD, Acheson D, Risbrough VB, Drummond SPA. Sleep Deprivation Disrupts Recall of Conditioned Fear Extinction. Biol Psychiatry Cogn Neurosci Neuroimaging. 2017 Mar; 2(2):123-129. PMID: 28758152.
        View in: PubMed
      4. Glenn DE, Acheson D, Geyer MA, Nievergelt CM, Baker DG, Risbrough VB. HIGH AND LOW THRESHOLD FOR STARTLE REACTIVITY ASSOCIATED WITH PTSD SYMPTOMS BUT NOT PTSD RISK: EVIDENCE FROM A PROSPECTIVE STUDY OF ACTIVE DUTY MARINES. Depress Anxiety. 2016 Mar; 33(3):192-202. PMID: 26878585.
        View in: PubMed
      5. Acheson D, Risbrough VB. Oxytocin Enhancement of Fear Extinction: A New Target for Facilitating Exposure-Based Treatments? Biol Psychiatry. 2015 Aug 1; 78(3):154-5. PMID: 26143973.
        View in: PubMed
      6. Acheson D, Eyler LT, Resovsky J, Tsan E, Risbrough VB. Fear extinction memory performance in a sample of stable, euthymic patients with bipolar disorder. J Affect Disord. 2015 Oct 1; 185:230-8. PMID: 26247493.
        View in: PubMed
      7. Powell SB, Khan A, Young JW, Scott CN, Buell MR, Caldwell S, Tsan E, de Jong LA, Acheson D, Lucero J, Geyer MA, Behrens MM. Early Adolescent Emergence of Reversal Learning Impairments in Isolation-Reared Rats. Dev Neurosci. 2015; 37:253-62. PMID: 26022788.
        View in: PubMed
      8. Acheson D, Feifel D, Kamenski M, Mckinney R, Risbrough VB. Intranasal oxytocin administration prior to exposure therapy for arachnophobia impedes treatment response. Depress Anxiety. 2015 Jun; 32(6):400-7. PMID: 25826649.
        View in: PubMed
      9. Acheson D, Geyer MA, Baker DG, Nievergelt CM, Yurgil K, Risbrough VB. Conditioned fear and extinction learning performance and its association with psychiatric symptoms in active duty Marines. Psychoneuroendocrinology. 2015 Jan; 51:495-505. PMID: 25444643.
        View in: PubMed
      10. Marshall AJ, Acheson D, Risbrough VB, Straus LD, Drummond SP. Fear conditioning, safety learning, and sleep in humans. J Neurosci. 2014 Aug 27; 34(35):11754-60. PMID: 25164670.
        View in: PubMed
      11. Acheson D, Geyer MA, Risbrough VB. Psychophysiology in the study of psychological trauma: where are we now and where do we need to be? Curr Top Behav Neurosci. 2014; 21:157-83. PMID: 25158622.
        View in: PubMed
      12. van Enkhuizen J, Acheson D, Risbrough V, Drummond S, Geyer MA, Young JW. Sleep deprivation impairs performance in the 5-choice continuous performance test: Similarities between humans and mice. Behav Brain Res. 2014 Mar 15; 261:40-8. PMID: 24333377.
        View in: PubMed
      13. Klabunde M, Acheson D, Boutelle KN, Matthews SC, Kaye WH. Interoceptive sensitivity deficits in women recovered from bulimia nervosa. Eat Behav. 2013 Dec; 14(4):488-92. PMID: 24183142.
        View in: PubMed
      14. Acheson D, Twamley EW, Young JW. Reward learning as a potential target for pharmacological augmentation of cognitive remediation for schizophrenia: a roadmap for preclinical development. Front Neurosci. 2013; 7:103. PMID: 23785309.
        View in: PubMed
      15. Acheson D, Feifel D, de Wilde S, McKinney R, Lohr J, Risbrough V. The effect of intranasal oxytocin treatment on conditioned fear extinction and recall in a healthy human sample. Psychopharmacology (Berl). 2013 Sep; 229(1):199-208. PMID: 23644911.
        View in: PubMed
      16. Acheson D, Stein MB, Paulus MP, Ravindran L, Simmons AN, Lohr JB, Risbrough VB. Effects of anxiolytic treatment on potentiated startle during aversive image anticipation. Hum Psychopharmacol. 2012 Jul; 27(4):419-27. PMID: 22782542.
        View in: PubMed
      17. Acheson D, Stein MB, Paulus MP, Geyer MA, Risbrough VB. The effect of pregabalin on sensorimotor gating in 'low' gating humans and mice. Neuropharmacology. 2012 Sep; 63(3):480-5. PMID: 22575075.
        View in: PubMed
      18. Acheson D, Forsyth JP, Moses E. Interoceptive fear conditioning and panic disorder: the role of conditioned stimulus-unconditioned stimulus predictability. Behav Ther. 2012 Mar; 43(1):174-89. PMID: 22304889.
        View in: PubMed
      19. Acheson D, Gresack JE, Risbrough VB. Hippocampal dysfunction effects on context memory: possible etiology for posttraumatic stress disorder. Neuropharmacology. 2012 Feb; 62(2):674-85. PMID: 21596050.
        View in: PubMed
      20. Acheson D, Forsyth JP, Prenoveau JM, Bouton ME. Interoceptive fear conditioning as a learning model of panic disorder: an experimental evaluation using 20% CO(2)-enriched air in a non-clinical sample. Behav Res Ther. 2007 Oct; 45(10):2280-94. PMID: 17548049.
        View in: PubMed
      Dean's Networks
      Concepts
      Derived automatically from this person's publications.
      _
      Co-Authors
      People in Profiles who have published with this person.
      _
      Similar People
      People who share similar concepts with this person.
      _
      Same Department
      Physical Neighbors
      People whose addresses are nearby this person.
      _